| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/12/2004 | CN1495184A Substituted purine derivative, its preparation method, application and composition containing it |
| 05/12/2004 | CN1495174A Preparation method of isoxazolylalkyldione compound |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1494914A Prduction method of holothurian oral lozenge |
| 05/12/2004 | CN1494913A Application of polygonatum polyscaccharide |
| 05/12/2004 | CN1494909A Phytosterol and/or plant steroid alkanol derivative |
| 05/12/2004 | CN1494902A Application of high-solubility berberine in preparation of medicine. |
| 05/12/2004 | CN1494899A Slowly-released dosage form containing asperline |
| 05/12/2004 | CN1149223C Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/12/2004 | CN1149212C Peperidine derivatives as reuptake inhibitors |
| 05/12/2004 | CN1149209C Triazole compounds with dopamine-D3-receptor affinity |
| 05/12/2004 | CN1149205C Polycyclic thiazole systems and their utilization as anorectics |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 05/12/2004 | CN1149201C Novel spiro imidazoline compounds, their prepn. method and medicinal compsns. containing same |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/12/2004 | CN1149195C 5-HTIF agonists |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/12/2004 | CN1149097C Chinese patent medicine for curing diabetes |
| 05/12/2004 | CN1149077C Rapidly disintegrable solid preparation |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734301 2,3,4,5-Tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds |
| 05/11/2004 | US6734214 Treating at least one of diabetes and complications arising from diabetes in a subject by administering to the subject a therapeutically effective amount of a mixture of polylactic acids |
| 05/11/2004 | US6734199 Such as n-((4-benzyloxyphenyl)-methyl)-5-((2,4-dioxothiazolidin-5-yl)methyl)-2 -methoxybenzamide, hypoglycemic and lipid lowering effect via peroxisome proliferator-activated receptor |
| 05/11/2004 | US6734197 Combination therapy for type II diabetes or Syndrome X |
| 05/11/2004 | US6734193 (1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734175 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor |
| 05/11/2004 | US6734170 Cellular uptake of bioactive agents |
| 05/11/2004 | US6734169 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 05/11/2004 | US6734162 Mixture of buffer, zinc, phenolic preservative and isotonic agent |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733782 Core tablet for controlled release of gliclazide after oral administration |
| 05/11/2004 | CA2284482C Treatment of cardiomyopathy |
| 05/11/2004 | CA2279428C Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 05/06/2004 | WO2004037861A2 Neutralizing antibodies against gdf-8 and uses therefor |
| 05/06/2004 | WO2004037859A1 Glp-1 derivatives and transmicosal absorption preparations thereof |
| 05/06/2004 | WO2004037829A1 Novel benzoxazole or oxazolopyridine compounds, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037823A1 Purine compounds and uses thereof as cannabinoid receptor ligands |
| 05/06/2004 | WO2004037806A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them |
| 05/06/2004 | WO2004037805A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | WO2004037791A1 Inhibitors of glycogen synthase kinase 3 |
| 05/06/2004 | WO2004037778A1 Substituted tetralins and indanes |
| 05/06/2004 | WO2004037777A1 Treating syndrome x with substituted tetralins and indanes |
| 05/06/2004 | WO2004037776A2 Novel compounds and their use as prar-modulators |
| 05/06/2004 | WO2004037775A1 Novel compounds useful in treating ppar mediated diseases |
| 05/06/2004 | WO2004037290A1 Sustained release composition for oral administration of drugs |
| 05/06/2004 | WO2004037277A2 Use of ingap for reversing diabetes |
| 05/06/2004 | WO2004037268A1 Prostaglandin compounds for the treatment of obesity |
| 05/06/2004 | WO2004037251A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/06/2004 | WO2004037248A2 Modulation of peroxisome proliferator activated receptors activity |
| 05/06/2004 | WO2004037195A2 Treatment of diabetes |
| 05/06/2004 | WO2004037184A2 Methods for the treatment of skin disorders |
| 05/06/2004 | WO2004037173A2 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | WO2004037169A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/06/2004 | WO2004024102A3 Cosmetic or pharmaceutical composition comprising a genus halopteris brown alga extract |
| 05/06/2004 | WO2004018451A8 Pyridazinone-derivatives as pde4 inhibitors |
| 05/06/2004 | WO2004015113A3 Albumin-fused ciliary neurotrophic factor |
| 05/06/2004 | WO2004009585A3 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors |
| 05/06/2004 | WO2004001002A3 Novel anticholesterol compositions and method for using same |
| 05/06/2004 | WO2004000042A3 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 05/06/2004 | WO2003106428A8 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 05/06/2004 | WO2003105893A3 Probiotic therapies using lactobacillus reuteri |
| 05/06/2004 | WO2003105838A3 MODULATION OF ACTIVATION OF GLUCOCORTICOID RECEPTORS beta-BREAKDOWN PRODUCTS OF GLUCOCORTICOIDS |
| 05/06/2004 | WO2003104254A3 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/06/2004 | WO2003101376A3 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | WO2003082853A8 New compounds |
| 05/06/2004 | WO2003045316A9 Polynucleotide therapy |
| 05/06/2004 | WO2003016351B1 N - cam related compounds modulating cell groth |
| 05/06/2004 | WO2003010314A3 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 05/06/2004 | WO2003007732A3 Pet food composition for regulating body weight and preventing obesity and related disorders in pets |
| 05/06/2004 | WO2003005971A8 Tetracycline compounds having target therapeutic activities |
| 05/06/2004 | WO2003004467A3 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 05/06/2004 | WO2002102800A9 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors |
| 05/06/2004 | WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 05/06/2004 | WO2002088078A3 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES |
| 05/06/2004 | WO2002087510A3 Subcellular targeting of therapeutic proteins |
| 05/06/2004 | WO2002056881A8 Fenofibrate tablets |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087789 Treating Alzheimer's disease, peripheral neuropathy, seizure disorder and/or diabetes |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087654 Nitric oxide synthase inhibitor phosphate salt |
| 05/06/2004 | US20040087645 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 05/06/2004 | US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size |
| 05/06/2004 | US20040087638 Antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders; side effect reduction |
| 05/06/2004 | US20040087637 Antiserotonine agents; central nervous system disorders |
| 05/06/2004 | US20040087635 Administering insulin sensitizer; benign prostatic hyperplasia |
| 05/06/2004 | US20040087632 Controlling metabolism of lipids, cholesterol |
| 05/06/2004 | US20040087630 Combinations |
| 05/06/2004 | US20040087629 Tartrate salts of thiazolidinedione derivative |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087625 Dietetics; antilipemic agents; anticholesterol agents; reducing triglycerides |
| 05/06/2004 | US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases |
| 05/06/2004 | US20040087598 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/06/2004 | US20040087597 Preventives and remedies for complications of diabetes |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087557 Treating muscle wasting with selective androgen receptor modulators |
| 05/06/2004 | US20040087553 Diterpene compounds; prophylaxis of hypercholesterolemia and hypertriglyceridemia |